EPISODE · Jan 28, 2026 · 5 MIN
FDA Approves Label Supplement for iDose TR
from Eyewire News: The Podcast · host Eyewire News
The FDA approves a key label supplement for Glaukos’ iDoseTR; Nidek announces the European launch of a new open-field refraction system; and there have been several leadership changes announced during the first month of 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
FDA Approves Label Supplement for iDose TR
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m